mRNA COVID-19 vaccine elicits potent adaptive immune response without the acute inflammation of SARS-CoV-2 infection

mRNA新冠疫苗可诱导强效的适应性免疫反应,而不会引起SARS-CoV-2感染的急性炎症。

阅读:9
作者:Ellie N Ivanova ,Jasmine Shwetar ,Joseph C Devlin ,Terkild B Buus ,Sophie Gray-Gaillard ,Akiko Koide ,Amber Cornelius ,Marie I Samanovic ,Alberto Herrera ,Eleni P Mimitou ,Chenzhen Zhang ,Trishala Karmacharya ,Ludovic Desvignes ,Niels Ødum ,Peter Smibert ,Robert J Ulrich ,Mark J Mulligan ,Shohei Koide ,Kelly V Ruggles ,Ramin S Herati ,Sergei B Koralov

Abstract

SARS-CoV-2 infection and vaccination elicit potent immune responses. Our study presents a comprehensive multimodal single-cell analysis of blood from COVID-19 patients and healthy volunteers receiving the SARS-CoV-2 vaccine and booster. We profiled immune responses via transcriptional analysis and lymphocyte repertoire reconstruction. COVID-19 patients displayed an enhanced interferon signature and cytotoxic gene upregulation, absent in vaccine recipients. B and T cell repertoire analysis revealed clonal expansion among effector cells in COVID-19 patients and memory cells in vaccine recipients. Furthermore, while clonal αβ T cell responses were observed in both COVID-19 patients and vaccine recipients, expansion of clonal γδ T cells was found only in infected individuals. Our dataset enables side-by-side comparison of immune responses to infection versus vaccination, including clonal B and T cell responses. Our comparative analysis shows that vaccination induces a robust, durable clonal B and T cell responses, without the severe inflammation associated with infection.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。